CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) solicits applications for the early-stage development of therapeutics to mitigate the adverse health effects resulting from toxic chemical exposure....
This page is a Member Feature!

Our funder profiles contain contact information, application deadlines, eligibility requirements, financial information, and more.

You can view a sample funder profile.

Log in or join to become a Member today!

Note: If you access GrantStation through a partner, log in through their website first, and then follow the link to GrantStation. Then refresh this page to view this content.